ZEPATIER (ELBASAVIR AND GRAZOPREVIR) TABLETS

ZEPATIER is a fixed-dose combination tablet containing elbasvir and grazoprevir for oral administration. Elbasvir is an HCV NS5A inhibitor, and grazoprevir is an HCV NS3/4A protease inhibitor. Each tablet contains 50 mg elbasvir and 100 mg grazoprevir.

Zepatier (elbasavir and grazoprevir) Tablets suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

SOURCING:

Alleviare Life Sciences connects the buyer with the supplier who can ship Zepatier (elbasavir and grazoprevir) Hepatitis Treatment Medicines) to any country of the world as per the buyer’s requirement and Government regulations of the country. ZEPATIER is manufactured by Amgen, Inc.

Alleviare Life Sciences provides options for choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

The order for Zepatier (elbasavir and grazoprevir) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Zepatier is a fixed-dose combination product containing elbasvir, a hepatitis C virus (HCV) NS5A inhibitor, and grazoprevir, an HCV NS3/4A protease inhibitor, and is indicated with or without ribavirin for treatment of chronic HCV genotypes 1 or 4 infections in adults.

Medicine Name: ZEPATIER
Generic Name: Elbasavir and Grazoprevir
Approval Date: Jan 28, 2016
Available as (Form & Strength): Tablets: 50 mg elbasvir and 100 mg grazoprevir
Company Name: Merck co